JP2019214626A5 - - Google Patents

Download PDF

Info

Publication number
JP2019214626A5
JP2019214626A5 JP2019176572A JP2019176572A JP2019214626A5 JP 2019214626 A5 JP2019214626 A5 JP 2019214626A5 JP 2019176572 A JP2019176572 A JP 2019176572A JP 2019176572 A JP2019176572 A JP 2019176572A JP 2019214626 A5 JP2019214626 A5 JP 2019214626A5
Authority
JP
Japan
Prior art keywords
formula
compound
reaction mixture
forming
under conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019176572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019214626A (ja
JP7063865B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019214626A publication Critical patent/JP2019214626A/ja
Publication of JP2019214626A5 publication Critical patent/JP2019214626A5/ja
Priority to JP2022016438A priority Critical patent/JP7333843B2/ja
Application granted granted Critical
Publication of JP7063865B2 publication Critical patent/JP7063865B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019176572A 2014-09-16 2019-09-27 Toll様受容体モジュレーターを調製する方法 Active JP7063865B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022016438A JP7333843B2 (ja) 2014-09-16 2022-02-04 Toll様受容体モジュレーターを調製する方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462051044P 2014-09-16 2014-09-16
US62/051,044 2014-09-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018134200A Division JP6596127B2 (ja) 2014-09-16 2018-07-17 Toll様受容体モジュレーターを調製する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022016438A Division JP7333843B2 (ja) 2014-09-16 2022-02-04 Toll様受容体モジュレーターを調製する方法

Publications (3)

Publication Number Publication Date
JP2019214626A JP2019214626A (ja) 2019-12-19
JP2019214626A5 true JP2019214626A5 (https=) 2020-02-06
JP7063865B2 JP7063865B2 (ja) 2022-05-09

Family

ID=54291584

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017514494A Active JP6373490B2 (ja) 2014-09-16 2015-09-14 Toll様受容体モジュレーターを調製する方法
JP2018134200A Active JP6596127B2 (ja) 2014-09-16 2018-07-17 Toll様受容体モジュレーターを調製する方法
JP2019176572A Active JP7063865B2 (ja) 2014-09-16 2019-09-27 Toll様受容体モジュレーターを調製する方法
JP2022016438A Active JP7333843B2 (ja) 2014-09-16 2022-02-04 Toll様受容体モジュレーターを調製する方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2017514494A Active JP6373490B2 (ja) 2014-09-16 2015-09-14 Toll様受容体モジュレーターを調製する方法
JP2018134200A Active JP6596127B2 (ja) 2014-09-16 2018-07-17 Toll様受容体モジュレーターを調製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022016438A Active JP7333843B2 (ja) 2014-09-16 2022-02-04 Toll様受容体モジュレーターを調製する方法

Country Status (20)

Country Link
US (1) US9573952B2 (https=)
EP (3) EP3461828B1 (https=)
JP (4) JP6373490B2 (https=)
KR (3) KR102306860B1 (https=)
CN (2) CN115043840A (https=)
AR (1) AR101882A1 (https=)
AU (2) AU2015318062B2 (https=)
BR (1) BR112017005100A2 (https=)
CA (1) CA2960384C (https=)
EA (1) EA201790373A1 (https=)
ES (3) ES2845205T3 (https=)
IL (1) IL250849A0 (https=)
MX (1) MX2017003288A (https=)
NZ (1) NZ729526A (https=)
PL (2) PL3848375T3 (https=)
PT (2) PT3194402T (https=)
SG (1) SG11201701472VA (https=)
SI (1) SI3461828T1 (https=)
TW (2) TWI780423B (https=)
WO (1) WO2016044183A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53347B (sr) 2008-12-09 2014-10-31 Gilead Sciences, Inc. Modulatori toll-sličnih receptora
JP6522732B2 (ja) 2014-07-11 2019-05-29 ギリアード サイエンシーズ, インコーポレイテッド Hivを治療するためのトール様受容体の調節因子
SG11201701520TA (en) 2014-09-16 2017-04-27 Gilead Sciences Inc Solid forms of a toll-like receptor modulator
TW201915000A (zh) * 2017-09-22 2019-04-16 大陸商江蘇恆瑞醫藥股份有限公司 稠合雜芳基衍生物、其製備方法及其在醫藥上的應用
TWI810456B (zh) 2019-05-22 2023-08-01 美商基利科學股份有限公司 Tlr7調節化合物及hiv疫苗之組合
CA3249821A1 (en) * 2022-04-26 2023-11-02 Bigelow Laboratory For Ocean Sciences PRODUCTION PROCESSES FOR HALOGENATED COMPOUNDS

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
JP2886570B2 (ja) 1989-09-29 1999-04-26 エーザイ株式会社 縮合ヘテロ環を有する化合物
JPH05320143A (ja) * 1992-03-18 1993-12-03 Mochida Pharmaceut Co Ltd 新規ピリミジン誘導体
TW274550B (https=) 1992-09-26 1996-04-21 Hoechst Ag
EP0743855A1 (en) 1994-01-03 1996-11-27 Acea Pharmaceuticals, Inc. 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
ZA973884B (en) 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
BR9710808A (pt) 1996-08-06 1999-08-17 Pfizer Derivados biciclicos 6,6 ou 6,7 contendo pirito ou pirimido substitu¡dos
US5693641A (en) 1996-08-16 1997-12-02 Berlex Laboratories Inc. Bicyclic pyrimidine derivatives and their use as anti-coagulants
WO2000000478A1 (en) 1998-06-26 2000-01-06 Bristol-Myers Squibb Pharma Company Substituted quinoxalin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
US7169778B2 (en) 1999-09-15 2007-01-30 Warner-Lambert Company Pteridinones as kinase inhibitors
US6452325B1 (en) 2000-07-24 2002-09-17 Thermoplastic Processes, Inc. Shatterproofing of fluorescent lamps
WO2002076954A1 (en) 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
US6806272B2 (en) 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
UA76512C2 (en) 2001-09-04 2006-08-15 Boehringer Ingelheim Pharma Dihydropteridinones, a method for producing thereof and use thereof as medicament
JP3876265B2 (ja) 2003-02-26 2007-01-31 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト ジヒドロプテリジノン、その製造方法及び薬物形態での使用
EP2269638A3 (en) 2004-05-28 2012-06-13 GlaxoSmithKline Biologicals S.A. Vaccine compositions comprising virosomes and a saponin adjuvant
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
AU2006242920A1 (en) 2005-05-04 2006-11-09 Pfizer Limited 2-amido-6-amino-8-oxopurine derivatives as Toll-Like receptor modulators for the treatment of cancer and viral infections, such as hepatitis C
CA2617589A1 (en) 2005-08-03 2007-02-08 Boehringer Ingelheim International Gmbh Dihydropteridinones in the treatment of respiratory diseases
US20090105212A1 (en) 2005-09-22 2009-04-23 Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan Novel adenine compound
EP2657235A1 (en) * 2005-10-28 2013-10-30 Ono Pharmaceutical Co., Ltd. Compound containing basic group and use thereof
WO2007103554A1 (en) * 2006-03-08 2007-09-13 Amgen Inc. Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
EP2004193A2 (en) 2006-03-13 2008-12-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
JP2009541284A (ja) 2006-06-23 2009-11-26 アストラゼネカ・アクチエボラーグ プテリジン誘導体およびカテプシン阻害剤としてのそれらの使用
MX337906B (es) 2006-10-19 2016-03-28 Signal Pharm Llc Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
AR065372A1 (es) 2007-02-19 2009-06-03 Smithkline Beecham Corp Derivados de purina
AU2008228303B2 (en) 2007-03-22 2012-04-19 Takeda Pharmaceutical Company Limited Substituted pyrimidodiazepines useful as PLK1 inhibitors
KR20120003499A (ko) * 2007-04-05 2012-01-10 지멘스 메디컬 솔루션즈 유에스에이, 인크. 클릭 화학을 이용한 탄산탈수효소―ⅰⅹ에 대한 분자 영상화 프로브의 제조
US20100179109A1 (en) * 2007-04-05 2010-07-15 Baldwin Jonh J Renin inhibitors
ES2441196T3 (es) * 2007-04-18 2014-02-03 Kissei Pharmaceutical Co., Ltd. Derivado de anillo condensado nitrogenado, composiciones farmacéuticas que lo contienen, y su uso con fines médicos
AU2008287339A1 (en) 2007-08-15 2009-02-19 Vertex Pharmaceuticals Incorporated 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5H-pyrimido [4, 5-b][1, 4] diazepin-2-ylamino)-3-methoxybenzamide Derivatives as Inhibitors of the Human Protein Kinases PLK1 to PLK4 for the Treatment of Proliferative Diseases
WO2009022185A2 (en) 2007-08-16 2009-02-19 Astrazeneca Ab 6, 6-fused heterocycles, their pharmaceutical compositions and methos of use
US20090291938A1 (en) 2007-11-19 2009-11-26 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
CN101284810A (zh) * 2008-06-02 2008-10-15 秦引林 氰基吡咯烷和氰基噻唑烷衍生物
RS53347B (sr) * 2008-12-09 2014-10-31 Gilead Sciences, Inc. Modulatori toll-sličnih receptora
CA2772253C (en) * 2009-09-14 2018-02-27 Gilead Sciences, Inc. Modulators of toll-like receptors
US20130273005A1 (en) * 2010-12-20 2013-10-17 Gilead Sciences, Inc. Methods for treating hcv

Similar Documents

Publication Publication Date Title
JP2019214626A5 (https=)
JP2019516692A5 (https=)
JP3989377B2 (ja) プロスタグランジン誘導体の製造方法及びその立体特異的出発物質
JP5048408B2 (ja) 臭化チオトロピウムの調製方法
JP2008510762A5 (https=)
JP2005501841A5 (https=)
JP2010532365A5 (https=)
JP2013520495A5 (https=)
JP2009544591A (ja) 臭化3(r)−(2−ヒドロキシ−2,2−ジチエン−2−イルアセトキシ)−1−(3−フェノキシプロピル)−1−アゾニアビシクロ[2.2.2]オクタンの製造方法
JP2019524752A5 (https=)
JP2008540414A5 (https=)
JP2022116171A5 (https=)
JP2006518765A5 (https=)
JPS6140234B2 (https=)
JP4681617B2 (ja) ヒンバシンアナログの合成
JP2006528215A5 (https=)
JP4580758B2 (ja) プロスタグランジン誘導体の製造方法及びその出発物質
JP2018505179A5 (https=)
JP2004269891A5 (https=)
JP2007529433A5 (https=)
JP2011102328A (ja) ケトンアミドの調製
JPH11279486A5 (ja) 光硬化性塗料組成物、塗装仕上げ方法および塗装物品
JP2004018389A5 (https=)
CN110407902B (zh) 一种甾体化合物脱除17-乙酰氧基的方法
TW201309716A (zh) β-核苷的合成技術